JLB & Associates Inc. Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC)

JLB & Associates Inc. decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 4.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 78,132 shares of the company’s stock after selling 3,469 shares during the period. JLB & Associates Inc.’s holdings in Henry Schein were worth $5,407,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of HSIC. CIBC Asset Management Inc boosted its holdings in Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after buying an additional 169 shares during the period. Cromwell Holdings LLC lifted its position in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares in the last quarter. Studio Investment Management LLC boosted its holdings in shares of Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after acquiring an additional 172 shares during the period. Central Pacific Bank Trust Division raised its stake in shares of Henry Schein by 2.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after purchasing an additional 200 shares during the period. Finally, Sanctuary Advisors LLC raised its stake in shares of Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock valued at $294,000 after purchasing an additional 203 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 0.3 %

HSIC opened at $78.05 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business’s fifty day simple moving average is $74.13 and its 200 day simple moving average is $72.15. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The stock has a market cap of $9.73 billion, a PE ratio of 32.12, a P/E/G ratio of 2.12 and a beta of 0.91.

Analyst Upgrades and Downgrades

Several brokerages have commented on HSIC. Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Barrington Research boosted their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th. Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.